BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25870092)

  • 1. Sequencing and combining systemic therapies for pancreatic neuroendocrine tumors.
    Kulke MH
    J Clin Oncol; 2015 May; 33(14):1534-8. PubMed ID: 25870092
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic neuroendocrine neoplasms.
    Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for advanced pancreatic neuroendocrine tumors.
    Kulke MH
    Semin Oncol; 2013 Feb; 40(1):75-83. PubMed ID: 23391115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib and everolimus in pancreatic neuroendocrine tumors.
    Procopio G; Pusceddu S; Buzzoni R
    Tumori; 2012; 98(3):394. PubMed ID: 22825518
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumors: treatment updates.
    Khagi S; Saif MW
    JOP; 2013 Jul; 14(4):367-71. PubMed ID: 23846929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic NETs: where do we stand now?
    Faivre S; Castellano D; Strosberg J; González E; Salazar R
    Cancer Metastasis Rev; 2014 Mar; 33(1):361-6. PubMed ID: 24452757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy for neuroendocrine tumours].
    Tóth M
    Orv Hetil; 2013 Sep; 154(39):1556-64. PubMed ID: 24058101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and therapeutic strategy for pancreatic neuroendocrine tumors in Japan].
    Ito T; Igarashi H; Jensen RT; Takayanagi R
    Fukuoka Igaku Zasshi; 2012 Jul; 103(7):131-7. PubMed ID: 22978065
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
    Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
    Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine tumors of the pancreas: what's new. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Dimou AT; Syrigos KN; Saif MW
    JOP; 2010 Mar; 11(2):135-8. PubMed ID: 20208321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of gastroenteropancreatic neuroendocrine tumors.
    Phan AT
    Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):3-5. PubMed ID: 25768101
    [No Abstract]   [Full Text] [Related]  

  • 13. New target therapies for patients with neuroendocrine tumors of the pancreas.
    Baltogiannis G; Katsios C; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2011 Oct; 5(5):563-6. PubMed ID: 21910571
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroendocrine tumors: current recommendations for diagnosis and surgical management.
    Joseph S; Wang YZ; Boudreaux JP; Anthony LB; Campeau R; Raines D; O'Dorisio T; Go VL; Vinik AI; Cundiff J; Woltering EA
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):205-31, x. PubMed ID: 21349420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroenteropancreatic neuroendocrine tumours: an overview.
    Davies L; Weickert MO
    Br J Nurs; 2016 Feb 25-Mar 9; 25(4):S12-5. PubMed ID: 26911175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in pancreatic neuroendocrine tumor treatment.
    Mir O; Coriat R; Goldwasser F
    N Engl J Med; 2011 May; 364(19):1871; author reply 1873-4. PubMed ID: 21561358
    [No Abstract]   [Full Text] [Related]  

  • 17. Steve Jobs's cancer. Pancreatic neuroendocrine tumors are becoming more common (the bad news) and also more treatable (the good news).
    Harv Health Lett; 2012 Jan; 37(3):1-3. PubMed ID: 22400158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignancy prediction in endocrine pancreas neoplasias].
    Fernández-del Castillo C
    Rev Invest Clin; 2005; 57(3):481-7. PubMed ID: 16187709
    [No Abstract]   [Full Text] [Related]  

  • 19. [More attention should be paid to the understanding of gastroenteropancreatic neuroendocrine tumors].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):158-60. PubMed ID: 22780939
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic diarrhea and weight loss: pancreatic cancer - but which one?].
    Stiefelhagen P
    MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):30. PubMed ID: 24260917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.